 |
|
Obesity may hinder optimal control of blood pressure and cholesterol
October 26, 2009Edmonton - Obese patients taking medications to lower their blood pressure and cholesterol levels are less likely to reach recommended targets for these cardiovascular disease risk factors than their normal weight counterparts, according to new research presented at the 2009 Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society and the Heart and Stroke Foundation of Canada.
Dr. Vineet Bhan, a resident at the University of Toronto, sought to determine whether there were differences in reaching guideline-recommended targets for blood pressure and cholesterol levels according to body mass index (BMI) in a large number of individuals deemed to be at high risk for heart disease and stroke.
"In Canada, these high risk patients frequently do not reach their blood pressure and cholesterol targets," says Dr. Bhan. "The goal of our study was to see if obesity could be a factor."
He says that other studies have looked at obese individuals in the general population and found they were more likely to have high blood pressure, high cholesterol, and diabetes. "This, to our knowledge, is the first study looking at patients with established cardiovascular disease who are on treatment to see how obesity relates to the control of these risk factors," he says.
The study recruited 7,357 high risk patients who had a history of coronary artery disease, cerebrovascular disease, peripheral vascular disease, or diabetes plus additional cardiovascular risk factors from nine Canadian provinces. This observational study, based on two outpatient registries, took place from 2001 to 2004, recruiting 95 per cent of the patients from family physician offices. The registries were led by senior co-author, Dr. Shaun Goodman, and coordinated by the Canadian Heart Research Centre.
"Although a direct cause-and-effect relationship cannot be proven, our data would suggest that pharmacologic treatment alone without achieving optimal weight may not be adequate," says senior author, Dr. Andrew Yan. "This is a potentially important message to get across to clinicians, especially primary care physicians who are on the front line managing these high risk patients in the long term."
Patients were classified into three groups according to their BMI:
* normal weight (BMI <24.9)
* overweight (BMI 25 - 29.9)
* obese (BMI>30)
Researchers measured their rates of attaining guideline targets of blood pressure and cholesterol. The majority of patients (3,261) were obese; 2,791 were overweight, and 1,305 were normal weight. After controlling for age, sex, diabetes, use of pharmacologic therapies and other confounders, the investigators found that obese patients were less likely to attain blood pressure and HDL levels than overweight or normal weight patients. However, there was no significant difference with regard to attainment of LDL-cholesterol targets.
Overall, 42 per cent of patients attained guideline recommended blood pressure targets, and 21 per cent achieved both blood pressure and LDL-cholesterol targets. The rate of attainment was less for overweight, and still less for obese patients in comparison with normal weight individuals.
Among normal weight patients, 52 per cent reached blood pressure targets; among overweight patients, 47 per cent reached blood pressure targets; and among obese patients, 34 per cent reached blood pressure targets.
Dr. Charles Kerr, president of the Canadian Cardiovascular Society added that the firm linkage of obesity with a failure to achieve known targets for risk prevention in coronary artery disease is important. "It is very clear that there is an interaction here that is critical," says Dr. Kerr. "You can't as effectively lower your cholesterol or your blood pressure without losing the weight."
Obesity is associated with high blood pressure, high cholesterol, and diabetes - three well-known risk factors for cardiovascular disease (CVD). Current Canadian, European, and American guidelines call for lifestyle changes and, if necessary, medication to control these risk factors to reduce obesity-related morbidity and mortality.
Heart and Stroke Foundation of Canada
He says that other studies have looked at obese individuals in the general population and found they were more likely to have high blood pressure, high cholesterol, and diabetes. "This, to our knowledge, is the first study looking at patients with established cardiovascular disease who are on treatment to see how obesity relates to the control of these risk factors," he says.
The study recruited 7,357 high risk patients who had a history of coronary artery disease, cerebrovascular disease, peripheral vascular disease, or diabetes plus additional cardiovascular risk factors from nine Canadian provinces. This observational study, based on two outpatient registries, took place from 2001 to 2004, recruiting 95 per cent of the patients from family physician offices. The registries were led by senior co-author, Dr. Shaun Goodman, and coordinated by the Canadian Heart Research Centre.
"Although a direct cause-and-effect relationship cannot be proven, our data would suggest that pharmacologic treatment alone without achieving optimal weight may not be adequate," says senior author, Dr. Andrew Yan. "This is a potentially important message to get across to clinicians, especially primary care physicians who are on the front line managing these high risk patients in the long term."
Patients were classified into three groups according to their BMI:
* normal weight (BMI <24.9)
* overweight (BMI 25 - 29.9)
* obese (BMI>30)
Researchers measured their rates of attaining guideline targets of blood pressure and cholesterol. The majority of patients (3,261) were obese; 2,791 were overweight, and 1,305 were normal weight. After controlling for age, sex, diabetes, use of pharmacologic therapies and other confounders, the investigators found that obese patients were less likely to attain blood pressure and HDL levels than overweight or normal weight patients. However, there was no significant difference with regard to attainment of LDL-cholesterol targets.
Overall, 42 per cent of patients attained guideline recommended blood pressure targets, and 21 per cent achieved both blood pressure and LDL-cholesterol targets. The rate of attainment was less for overweight, and still less for obese patients in comparison with normal weight individuals.
Among normal weight patients, 52 per cent reached blood pressure targets; among overweight patients, 47 per cent reached blood pressure targets; and among obese patients, 34 per cent reached blood pressure targets.
Dr. Charles Kerr, president of the Canadian Cardiovascular Society added that the firm linkage of obesity with a failure to achieve known targets for risk prevention in coronary artery disease is important. "It is very clear that there is an interaction here that is critical," says Dr. Kerr. "You can't as effectively lower your cholesterol or your blood pressure without losing the weight."
Obesity is associated with high blood pressure, high cholesterol, and diabetes - three well-known risk factors for cardiovascular disease (CVD). Current Canadian, European, and American guidelines call for lifestyle changes and, if necessary, medication to control these risk factors to reduce obesity-related morbidity and mortality.
Heart and Stroke Foundation of Canada
Blood Pressure Current Events and Blood Pressure News RSSCanadians finding it tough to shake the salt habit
Canadians know that too much salt isn't good for their diets, but half still continue to shake it on, according to a new study by University of Alberta researchers.
Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health
A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep.
At-risk college students reduce HBP, anxiety, depression through Transcendental Meditation
The Transcendental Meditation technique may be an effective method to reduce blood pressure, anxiety, depression, and anger among at-risk college students, according to a new study to be published in the American Journal of Hypertension, December 2009.
Fat collections linked to decreased heart function
Researchers from Boston University School of Medicine (BUSM) have shown that fat collection in different body locations, such as around the heart and the aorta and within the liver, are associated with certain decreased heart functions.
Young athletes need dual screening tests for heart defects, study suggests
To best detect early signs of life-threatening heart defects in young athletes, screening programs should include both popular diagnostic tests, not just one of them, according to new research from heart experts at Johns Hopkins.
Heart and bone damage from low vitamin D tied to declines in sex hormones
Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone.
New study links vitamin D deficiency to cardiovascular disease and death
While mothers have known that feeding their kids milk builds strong bones, a new study by researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City suggests that Vitamin D contributes to a strong and healthy heart as well - and that inadequate levels of the vitamin may significantly increase a person's risk of stroke, heart disease, and death, even among people who've never had heart disease.
Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing.
Device enables world's first voluntary gorilla blood pressure reading
Zoo Atlanta recently became the first zoological institution in the world to obtain voluntary blood pressure readings from a gorilla.
Size matters: Obesity leading risk factor of left atrial enlargement during aging
Aside from aging itself, obesity appears to be the most powerful predictor of left atrial enlargement (LAE), upping one's risk of atrial fibrillation (the most common type of arrhythmia), stroke and death.
More Blood Pressure Current Events and Blood Pressure News Articles
 |
Omron HEM-780 Automatic Blood Pressure Monitor with ComFit Cuff by Omron 1-touch operation with up to 40% faster readings Extra-large digital display Features hypertension indicator, morning hypertension indicator & irregular heartbeat 2-person/200-total measurement memory with date & time stamp Features 8-week morning & 8-week evening averages per user ComFit (TM) cuff fits arms 9 - 17 in circumference Includes batteries, AC adapter & carrying case 5-year limited warranty |
 |
Omron HEM-712C Automatic Blood Pressure Monitor with IntelliSense by Omron Blood Pressure Monitor with Auto Inflatable Cuff / New and improved - now stores 14 readings in memory / Monitor your health with ease! New and improved - now stores 14 readings in memory |
 |
Omron HEM-790IT Automatic Blood Pressure Monitor with Advanced Omron Health Management Software by Omron Automatic Blood Pressure Monitor w/ComFit Cuff Portable blood pressure monitor detects morning hypertension and irregular heartbeats, simple, one-touch operation, extra large display, 2-user, 200 memory w/time/date stamp Includes Omron Health Management Software, ComFit Cuff, AC adaptor, carrying case, CD Rom, USB Cable, 4-AA batteries |
 |
Omron HEM-650 Wrist Blood Pressure Monitor with APS (Advanced Positioning Sensor) by Omron The Omron HEM Wrist Blood Pressure Monitor with with Advanced Positioning Sensor Technology is the newest wrist blood pressure monitor from Omron the leading brand of heart monitors recommended by more pharmacists and doctors |
 |
Omron HEM-711 DLX Automatic Blood Pressure Monitor with Comfit Cuff by Omron The brand new HEM-711DLX Automatic Blood Pressure Monitor by Omron Healthcare is at the cutting edge of blood pressure technology and the perfect way to keep a watchful eye on your health. It features Intelli-sence Technology for accurate readings up to 2.5 times faster than competitive products, and with its quiet 1-Touch automatic operation, using a blood pressure monitor has never been easier. The extra large digital display allows you to comfortably see systolic and diastolic blood pressure and pulse, as well as the date and time. Advanced Diagnostics options include: a hypertension indicator (according to the AHA guidelines), irregular heartbeat detector, excessive body motion detector, advanced averaging and a 60 memory storage with date and time stamp. The Comfit cuff is pre-formed... |
 |
Omron HEM-432C Manual Inflation Blood Pressure Monitor by Omron Omron HEM 432C Digital Blood Pressure Monitor-Manual Inflation |
 |
Omron HEM-670IT Wrist Blood Pressure Monitor with APS (Advanced Positioning Sensor) and Advanced Omron Health Management Software by Omron Omron HEM IT Automatic Wrist Blood Pressure Monitor has Advanced Positioning Sensor Technology which automatically confirms monitor is at heart level Detects Morning Hypertension Important Predictor of Increased Risk of Stroke |
 |
Panasonic EW3109W Upper Arm Blood Pressure Monitor (White) by Panasonic The Panasonic EW3109W Automatic Arm Blood Pressure Monitor is the first portable arm unit in the industry. The easy-fit cuff, designed for comfort and to assure correct and accurate use, rolls around the slim baton-style monitor for portability. The large "Easy Read" LCD display gives you digital readings on inflation with memory capabilities that can capture up to 90 readings with an averaging feature allowing you to save and track readings over time. Panasonic's Digital Filter Technology assures accurate measurement of blood pressure readings every time with sensors that isolate and detect only essential pulse oscillation, thereby eliminating noise factors which can cause unreliable measurements. The Flashing Warning System alerts you if your blood pressure reading is high or... |
 |
Wrist Style Blood Pressure Monitor by Get Organized Blood pressure monitor Simply slip over your wrist and press start. Oversized easy-to-read digital display shows your pulse and systolic/diastolic pressures.Memory recall, stores 60 previous readings with date and time. Comes with carrying case. Requires two AA batteries (not included). |
 |
Omron HEM 629 Auto Inflate Wrist Blood Pressure Monitor by Omron Clinically proven accuracy * Automatic inflation and deflation * 21 memory storage * Attached cuff for wrist sizes 5 1/3Ì to 7 2/3 * Operates on 2 AAA batteries (included) * Convenient carrying case * 5 year limited warranty * Shipping Carton Size: 12 L x 10 W x 6 H |
| © 2009 BrightSurf.com |